Yanyan Bikan Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- The company's stock will be delisted on the trading day following the end of the delisting adjustment period.
- The start date for the delisting adjustment period is June 19, 2023, with the expected last trading date being July 11, 2023.
- The company's stock will trade for fifteen trading days during the delisting adjustment period. As of the date of this announcement, the stock has traded for ten days, leaving five trading days remaining. Upon completion of the trading period, the stock will be delisted. Investors are advised to make prudent decisions and be aware of investment risks.
- During the delisting adjustment period, the company will not plan or implement any major asset restructuring matters.
- Investors and market participants such as securities companies should settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect businesses in a timely manner before the stock is delisted.
- For judicial freeze matters expiring after the stock is delisted and before the completion of the initial registration in the delisting sector, it is recommended that the competent authorities handle the renewal procedures in advance through the original enforcement channels before the stock is delisted.